Pediatric Vaccines Market By Type (Multivalent and Monovalent), Technology (Conjugate, Live Attenuated, Toxoid, Subunit, Inactivated and Others) and Application (Allergy, Cancer and Infectious Disease) - Global Industry Analysis And Forecast To 2025
Pediatric is a branch of medicine that deals with medical care (diagnostics and treatments) of infants, children and adolescents. The word pediatrics means “healer of children”. Pediatric Vaccines use is growing due to factors like; reducing the healthcare spending, government’s initiatives to reduce the cost of patient’s immunization, rising number of vaccination programs, increase in development of new vaccines, increased presence of chronic disorders, etc. Therefore, the Pediatric Vaccines Market is anticipated to expand and has tremendous scope during the forecast period. The global Pediatric Vaccines Market anticipated to flourish in the future by growing at a significantly higher CAGR.
The global Pediatric Vaccines Market is based on segment, by Type the market is segmented into Multivalent and Monovalent; by Technology the market is segmented into Conjugate, Live Attenuated, Toxoid, Subunit, Inactivated and Others; and by Application the market is segmented into Allergy, Cancer and Infectious Disease.
Pediatric Vaccines Market, By Type
Pediatric Vaccines Market, By Technology
Pediatric Vaccines Market, By Application
On a global front, the Pediatric Vaccines Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the global Pediatric Vaccines Market due to increasing government support and investment in R&D by leading companies.
Pediatric Vaccines Market, By Region
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
The leading players in the market are Bio Med Pvt. Ltd., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation, Zydus Cadila, Pfizer Inc., GlaxoSmithKline plc., Serum Institute of India Pvt. Ltd., Merck Sharp & Dohme Corp., Indian Immunologicals Limited, Panacea Biotec, SANOFI and AstraZeneca. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
Bio Med Pvt. Ltd.
Sinovac Biotech Ltd.
Mitsubishi Tanabe Pharma Corporation
Serum Institute of India Pvt. Ltd.
Merck Sharp & Dohme Corp.
Indian Immunologicals Limited
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?